Clozapine and COVID-19: The authors respond (Letter)

Abstract

We compliment the authors and journal for ensuring the “Consensus statement on the use of clozapine during the COVID-19 pandemic” was published in a timely fashion. Coronavirus disease 2019 (COVID-19) rapidly transformed into a pandemic, challenging medicine in ways initially not imagined; this is certainly the case not only for treatmentresistant schizophrenia and for reasons related to clozapine, but also the patient population.